0000946724-18-000033.txt : 20181219 0000946724-18-000033.hdr.sgml : 20181219 20181219191038 ACCESSION NUMBER: 0000946724-18-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181217 FILED AS OF DATE: 20181219 DATE AS OF CHANGE: 20181219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLEMONS V GORDON CENTRAL INDEX KEY: 0000946724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19291 FILM NUMBER: 181244420 MAIL ADDRESS: STREET 1: 2010 MAIN STREET STREET 2: STE 600 CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORVEL CORP CENTRAL INDEX KEY: 0000874866 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 330282651 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 2010 MAIN STREE STREET 2: SUITE 1020 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9498511473 MAIL ADDRESS: STREET 1: 2010 MAIN STREET STREET 2: SUITE 1020 CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: FORTIS CORP DATE OF NAME CHANGE: 19600201 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-12-17 0 0000874866 CORVEL CORP CRVL 0000946724 CLEMONS V GORDON 2010 MAIN STREET SUITE 600 IRVINE CA 92614 1 1 0 0 Chairman of the Board Common Stock 2018-12-17 4 M 0 20000 45.55 A 1886790 D Common Stock 2018-12-17 4 F 0 14545 62.63 D 1872245 D Common Stock 2018-12-17 4 F 0 1633 62.63 D 1870612 D Common Stock 2018-12-18 4 S 0 1000 62.6822 D 1869612 D Common Stock 2018-12-19 4 S 0 1000 62.4383 D 1868612 D Non-Qualified Stock Option (right to buy) 45.55 2018-12-17 4 M 0 20000 62.63 D 2019-02-06 Common Stock 20000 0 D Sales reported above were made pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2018. The reported transaction was made by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. By: Sharon O'Connor For: Gordon Clemons 2018-12-19